Traders bought shares of CVS Health Corporation (NYSE:CVS) on weakness during trading hours on Thursday. $77.55 million flowed into the stock on the tick-up and $44.94 million flowed out of the stock on the tick-down, for a money net flow of $32.61 million into the stock. Of all equities tracked, CVS Health Corporation had the 39th highest net in-flow for the day. CVS Health Corporation traded down ($0.03) for the day and closed at $93.37

Several research analysts have issued reports on the company. Citigroup Inc. raised their target price on CVS Health Corporation from $105.00 to $115.00 and gave the stock a “neutral” rating in a research report on Monday, May 9th. Jefferies Group raised their target price on CVS Health Corporation from $110.00 to $122.00 and gave the stock a “buy” rating in a research report on Thursday, May 12th. FBR & Co reissued a “buy” rating on shares of CVS Health Corporation in a research report on Saturday, May 14th. Deutsche Bank AG raised their target price on CVS Health Corporation from $99.00 to $108.00 and gave the stock a “hold” rating in a research report on Wednesday, August 3rd. Finally, Zacks Investment Research raised CVS Health Corporation from a “sell” rating to a “hold” rating in a research report on Wednesday, August 3rd. Six analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $113.02.

The company has a market cap of $100.05 billion and a PE ratio of 21.59. The firm’s 50-day moving average is $95.90 and its 200-day moving average is $98.51.

CVS Health Corporation (NYSE:CVS) last posted its earnings results on Tuesday, August 2nd. The pharmacy operator reported $1.32 EPS for the quarter, topping the consensus estimate of $1.30 by $0.02. During the same period last year, the business earned $1.19 earnings per share. The company had revenue of $43.70 billion for the quarter, compared to analyst estimates of $44.28 billion. The firm’s revenue was up 17.6% on a year-over-year basis. On average, analysts forecast that CVS Health Corporation will post $5.86 earnings per share for the current year.

A number of institutional investors have modified their holdings of CVS. Dimensional Fund Advisors LP increased its position in shares of CVS Health Corporation by 8.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 8,937,908 shares of the pharmacy operator’s stock worth $873,912,000 after buying an additional 689,609 shares in the last quarter. Atlantic Trust Group LLC increased its position in shares of CVS Health Corporation by 6.5% in the fourth quarter. Atlantic Trust Group LLC now owns 1,402,695 shares of the pharmacy operator’s stock worth $137,141,000 after buying an additional 85,136 shares in the last quarter. Foresters Investment Management Company Inc. increased its position in shares of CVS Health Corporation by 6.1% in the fourth quarter. Foresters Investment Management Company Inc. now owns 545,860 shares of the pharmacy operator’s stock worth $53,369,000 after buying an additional 31,200 shares in the last quarter. Principal Financial Group Inc. increased its position in shares of CVS Health Corporation by 1.5% in the fourth quarter. Principal Financial Group Inc. now owns 1,676,916 shares of the pharmacy operator’s stock worth $163,952,000 after buying an additional 24,602 shares in the last quarter. Finally, Liberty Mutual Group Asset Management Inc. increased its position in shares of CVS Health Corporation by 58.8% in the fourth quarter. Liberty Mutual Group Asset Management Inc. now owns 65,866 shares of the pharmacy operator’s stock worth $6,440,000 after buying an additional 24,391 shares in the last quarter.

CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.